The 14 HealthTech Research Centres are based in leading NHS organisations across England.
Each centre operates on a national scale, with different clinical specialties.
We combine NHS clinical leadership, academic rigour, and industry insight to support technologies from early development through to NHS adoption, leveraging the full range of the NIHR’s research infrastructure.
We conduct robust investigations to provide real world evidence that demonstrates the economic value and public benefit for the NHS and its patients.
Patients and the public are partners in our work, shaping research and product development from initial conception through to adoption.
We partner with industry, universities, NHS organisations and patient groups to translate innovation into care.
We work closely with regulatory bodies including The Medicines and Healthcare products Regulatory Agency (MHRA) and The National Institute for Health and Care Excellence (NICE), and industry associations including The Association of British HealthTech Industries (ABHI) and The British In Vitro Diagnostics Association (BIVDA), to ensure our support aligns with regulatory requirements and industry needs.
We support innovators to apply for funding to provide the necessary capital to continue product development, and ensure they can generate the evidence necessary to apply for regulatory approvals.
To access i4i PDA grant writing resources please fill out this short form.
The National Institute of Health and Care Research have partnered with the product design consultancy Pd-m to deliver the NIHR Net Zero Catalyst. The three-month programme offers innovators hands-on support from academic, clinical and industry expertise in sustainability and HealthTech, providing practical approaches to embed sustainability in product development. The Catalyst is delivered in partnership with Pd-m, sustainability and product design specialists.
In alignment with the DHSC ‘Design for Life’ framework for establishing a circular economy of reuse, remanufacture and recycling in medical products, this three-month CPD accredited Catalyst equips innovators with practical approaches and knowledge to embed sustainability within their innovations.
A £5,000 prize fund will be awarded to exceptional innovators participating in the Catalyst to support future development and evidence generation for follow-on funding applications. Each cohort has 10 places and there are now no joining fees for this year's cohort.
Applicants to the Catalyst will be expected to:
By the end of the Catalyst, participating innovators will understand:
Innovators will also receive continued support from the Catalyst as their innovation progresses, including an expert panel feedback session. This support, alongside new knowledge, practical approaches and partnerships gained by innovators, will place them in a stronger position for future developmental funding. Successful completion of the programme will result in a CPD accredited certificate of attendance.
March 2026, online, 2 hours - The Catalyst team will set the stage for the programme, provide an overview of sustainable healthcare, and task the cohort with a self-study activity on Net-Zero policy in the NHS.
May 2026, online, 6 hours - The cohort will reflect on their learning from the first three sessions with peers from the Catalyst cohort, learn the principles of developing a Sustainable Value Proposition, and how to target this specifically to NHS procurement processes, and analyse the HealthTech funding landscape. The cohort will start developing a pitch that integrates their Sustainable Value Proposition, in preparation for the next session (Innovation Showcase).
June 2026, 2-3 hours - Each member of the Catalyst cohort will develop and deliver a final pitch for their innovation, highlighting how they have integrated learning from the Catalyst. Awards and prize funds for exceptional innovators will be announced, and each member of the cohort will receive a 1-to-1 post-programme debrief with the Catalyst team.
For the spring ’26 cohort we will not be taking on purely digital innovations as we don’t feel the current format would benefit your innovation. We do however recognise digital HealthTech's potential for significant sustainability gains through patient pathway improvements. It is our ambition to include digital in future cohorts.
So long as there is a physical device this type of innovation is welcome. The programme focuses on manufacture, materials and related circular practices which aren’t relevent to a purely digital innovation.
The Catalyst is open to all; however, innovators from outside the UK should aim to bring their innovation to the UK market, either through introduction to the NHS or by seeking to access NIHR funding in partnership with UK collaborators to support further development. Please note that cohort members are expected to attend in‑person events in the UK, and travel costs are not covered by the programme. To date, we have had engagement in the Catalyst from organisations across Europe.
Applying circular principles early makes them much easier to implement, particularly when they relate to material choices or business model changes. While our primary focus is on innovations at TRL 1–4, applicants at higher TRLs are also welcome and will be considered on a case‑by‑case basis. In these cases, having already completed some sustainability‑related work on your innovation will be viewed favourably, as it demonstrates a willingness to adopt sustainable practices such as those taught in this programme.
For more information watch our information session recording.
Pd-m: Founded in 2005, Pd-m is a Product Design and Sustainability consultancy with a focus on Health Technologies. The business works with a range of clients including boot-strapped start-ups to med tech multinationals, to embed sustainability into their organisations at a strategic and practical level.
NIHR Climate, Health & Sustainability (CHS): Responsible for NIHR’s mission to drive and promote sustainable health and care systems. The CHS team supports this mission by funding research, supporting knowledge mobilisation and building research capacity in climate, health and environmental sustainability.
NIHR HealthTech Research Centre Network: provides strategic leadership and coordination for NIHR’s 14 HealthTech Research Centres (HRCs). The Network’s ambition is to transform UK healthtech into a thriving ecosystem of industry, academia, and the NHS, bringing innovative healthtech solutions to patients more rapidly and driving economic growth.
NIHR HealthTech Research Centre in Accelerated Surgical Care: drives HealthTech innovation to deliver socio-economic benefit, through quicker diagnosis and treatment of surgical conditions. Sustainability and Net Zero is a cross-cutting research theme that focuses on the methods and technologies needed to reduce waste and promote sustainability.
The 14 HealthTech Research Centres are based in leading NHS organisations across England.
Each centre operates on a national scale, with different clinical specialties.
NIHR HealthTech Research Centre in Diagnostic and Technology Evaluation
NIHR HealthTech Research Centre in Accelerated Surgical Care
NIHR HealthTech Research Centre in Emergency and Acute Care
NIHR HealthTech Research Centre in Long Term Conditions
NIHR HealthTech Research Centre in Paediatrics and Child Health
NIHR HealthTech Research Centre in Mental Health (MindTech)
NIHR HealthTech Research Centre in Rehabilitation
NIHR HealthTech Research Centre in Devices, Digital and Robotics
NIHR HealthTech Research Centre in Brain Injury
NIHR HealthTech Research Centre in Community Healthcare
NIHR HealthTech Research Centre in Cardiovascular and Respiratory Medicine
NIHR HealthTech Research Centre in In Vitro Diagnostics
NIHR HealthTech Research Centre in Brain Health
By harnessing the trusted expertise of all HRCs, we offer a unified, coordinated approach that provides HealthTech companies with the support they need, shaped around their specific challenges and goals.
TRL 1-2, TRL 3
Identify and support seed funding applications and experimental and translational research funding (e.g., EPSRC, MRC, VCSEs)
TRL 4-6
Applications to larger grants to support clinical trials (e.g., UKRI, i4i FAST)
TRL 7
Applications for Heath Technology Assessment for evidence synthesis research
TRL 8, TRL 9
Identify and apply for venture capital funding for commercialisation
Identify and validate unmet patient need
Usability testing across different patient populations at a national level
Provision of patient involvement evidence to support application
Content, visual design, reliability, language and user instructions
Patient experience, benefits, risks and unexpected events
Unmet need validation
Care pathway analysis
Analytical validity and proof of concept
Clinical validity and evaluation
Regulatory approval and real world evidence
NICE approvals
Develop value proposition
Early health economics (e.g., value drivers, uncertainty modelling, pricing strategy)
Full health economics (e.g., Cost-Minimisation, Effectiveness, Benefit, Consequence Analysis, including Quality or Disability-Adjusted Life Year (QALY/DALY))
Adherence to NHS Supply Chain requirements for procurement
Knowledge and guidance for NHS care pathways
Access to clinical champions
Access to clinical engineering to support evidence generation
Access to Clinical Research and Innovation Governance
Access to commercialisation expertise through Trust partnerships (e.g., Medipex)
Access to NHS Supply Chain and other adoption specialists
Identify and embed carbon savings in design stage to meet sustainability (net zero) requirements
Develop a sustainable value proposition (circularity)
Health econometrics support to demonstrate sustainability gains (financial and health)
Provide evidence of meeting sustainability (net zero) requirements
Complete Evergreen Assessment an Carbon Reduction Plans in preparation for procurement
Adhering to NHS Net Zero requirements for registration and procurement frameworks (i.e., NHS Supply Chain)
Build entrepreneurship skills including grantsmanship
Product design capability (PPIE & Sustainability, value based procurement)
Certified health econometrics training to support evidence generation
Virtual regulatory training on evidence generation, legal compliance and certification
Access to accelerators, mentorship and placements to develop commercialisation skills
tbc: NHS Supply Chain training/webinar
Utilise regulatory partnerships to design evidence generation to overcome regulatory barriers
Collaborate across NIHR Infrastructure to test prototypes and utilise clinical trial facilities and populations
Utilise HRC partnerships with MHRA and NICE partnership to support regulatory approvals, Evaluation and development of Guidance
Establish collaboration partnerships to support commercialisation
Utilise HRC partnerships with NHS Supply Chain and other adoption specialists